NIH-funded research R21 grant

Improving stem cell therapy using special sugar-like materials.

Official title: Sugar-coating our way to genetically modified mesenchymal stem cells: Glycocalyx-inspired cell culture substrates that prime mesenchymal stem cells for polycation-mediated pDNA delivery.

Funded at Colorado School of Mines · NIH-10647120 · Data updated 2026-11-12

This study is looking at how to make special stem cells work better for treating autoimmune disorders and cancer by giving them a little genetic boost and using materials that help them grow, which could lead to safer and more effective treatments for these conditions.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionColorado School of Mines
NIH-funded
Lab location1 site (Golden, United States)
Project startAugust 11, 2023
Project endAugust 10, 2025
Funding year2023
Award (this year)$403,869
NIH project number1R21EB034464-01
Project IDNIH-10647120 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients suffering from autoimmune disorders or cancers who may benefit from advanced stem cell therapies.

Less likely to help

Patients with conditions unrelated to autoimmune disorders or cancer may not receive benefits from this research.

What this research studies

This research focuses on enhancing the effectiveness of human mesenchymal stem cells (hMSCs) for treating conditions like autoimmune disorders and cancer. The approach involves genetically modifying these stem cells to improve their healing properties, using innovative materials that mimic natural sugars to support their growth and function. By creating a specialized environment for the stem cells, the researchers aim to boost their ability to deliver therapeutic molecules while minimizing potential side effects. This could lead to more effective treatments for various diseases.

Why it matters

Potential benefit: If successful, this research could lead to more effective stem cell therapies for patients with autoimmune diseases and cancers.

How similar studies have gone: Other research has shown promise in using similar approaches to enhance stem cell therapies, indicating potential for success in this area.

Where this research is happening

  • Colorado School of Mines
    Golden, United States
    Active

Researchers

  • Principal investigator: Kumar, Ramya — Colorado School of Mines
  • Study coordinator: Kumar, Ramya

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.